Additive effect of PTK787/ZK 222584, a potent inhibitor of VEGFR phosphorylation, with Idarubicin in the treatment of acute myeloid leukemia
To access this article, please choose from the options below
PII: S0301-472X(09)00079-4
doi:10.1016/j.exphem.2009.03.001
© 2009 ISEH - Society for Hematology and Stem Cells. Published by Elsevier Inc. All rights reserved.
